Australia markets closed

AVXL Jan 2024 15.000 put

OPR - OPR Delayed price. Currency in USD
Add to watchlist
10.150.00 (0.00%)
As of 01:00PM EST. Market open.
Full screen
Previous close10.15
Open7.10
Bid0.00
Ask0.00
Strike15.00
Expiry date2024-01-19
Day's range7.10 - 7.10
Contract rangeN/A
Volume5
Open interestN/A
  • Motley Fool

    Is Anavex Life Sciences a Smart Stock to Buy Now?

    Shares of clinical-stage biotechnology company Anavex Life Sciences (NASDAQ: AVXL) recently shot higher. Investors reacting to great news for its Alzheimer's disease drug candidate, blarcamesine, drove the stock about 40% higher when the market opened on Friday, Dec. 2. Is Anavex Life Sciences a smart stock to buy now, or will the road ahead be a rocky one full of potholes?

  • GlobeNewswire

    Anavex Life Sciences to Announce Management Webcast and Conference Call on Monday December 5, 2022

    Webcast and Conference Call To be Held Monday December 5, 2022, 8:30 am ETNEW YORK, Dec. 02, 2022 (GLOBE NEWSWIRE) -- Anavex Life Sciences Corp. (“Anavex” or the “Company”) (Nasdaq: AVXL), a clinical-stage biopharmaceutical company developing differentiated therapeutics for the treatment of neurodegenerative and neurodevelopmental disorders including Alzheimer’s disease, Parkinson’s disease, Rett syndrome and other central nervous system (CNS) diseases, today announced that management will host

  • Motley Fool

    Why Anavex Life Sciences Stock Is Surging Today

    The biotech reported positive results from a phase 2b/3 study of its lead Alzheimer's disease candidate.